- Patent Title: Macrocyclic benzofuran compounds for the treatment of hepatitis C
-
Application No.: US15515170Application Date: 2015-10-01
-
Publication No.: US10202403B2Publication Date: 2019-02-12
- Inventor: Tao Wang , Zhongxing Zhang , John F. Kadow
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Elliott Korsen
- International Application: PCT/US2015/053375 WO 20151001
- International Announcement: WO2016/054299 WO 20160407
- Main IPC: C07D498/22
- IPC: C07D498/22 ; C07D493/04 ; C07D493/14 ; C07D498/04
Abstract:
Compounds of formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US20170217989A1 MACROCYCLIC BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Public/Granted day:2017-08-03
Information query
